Measurement of health-related quality of life in the national emphysema treatment trial
- PMID: 15364757
- DOI: 10.1378/chest.126.3.781
Measurement of health-related quality of life in the national emphysema treatment trial
Abstract
Purposes: To evaluate two generic and two disease-specific measures of health-related quality of life (QOL) using prerandomization data from the National Emphysema Treatment Trial (NETT).
Method: The analyses used data collected from the 1,218 subjects who were randomized in the NETT. Patients completed evaluations before and after completion of the prerandomization phase of the NETT pulmonary rehabilitation program. Using data obtained prior to participation in the rehabilitation program, QOL measures were evaluated against physiologic and functional criteria using correlational analysis. The physiologic criteria included estimates of emphysema severity based on FEV(1) and measures of Pao(2) obtained with the subject at rest and breathing room air. Functional measures included the 6-min walk distance (6MWD), maximum work, and hospitalizations in the prior 3 months.
Results: Correlation coefficients between QOL measures ranged from -0.31 to 0.70. In comparison to normative samples, scores on general QOL measures were low, suggesting that the NETT participants were quite ill. All QOL measures were modestly but significantly correlated with FEV(1), maximum work, and 6MWD. Patients who had stayed overnight in a hospital in the prior 3 months reported lower QOL on average than those who had not been hospitalized. There were significant improvements for all QOL measures following the rehabilitation program, and improvements in QOL were correlated with improvements in 6MWD.
Comment: The disease-specific and general QOL measures used in the NETT were correlated. Analyses suggested that these measures improved significantly following the rehabilitation phase of the NETT.
Similar articles
-
The effects of pulmonary rehabilitation in the national emphysema treatment trial.Chest. 2005 Dec;128(6):3799-809. doi: 10.1378/chest.128.6.3799. Chest. 2005. PMID: 16354848 Clinical Trial.
-
Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 1999 Dec;160(6):2018-27. doi: 10.1164/ajrccm.160.6.9902117. Am J Respir Crit Care Med. 1999. PMID: 10588623 Clinical Trial.
-
Impact of lung volume reduction surgery versus rehabilitation on quality of life.Eur Respir J. 2004 Feb;23(2):275-80. doi: 10.1183/09031936.03.00025203. Eur Respir J. 2004. PMID: 14979503 Clinical Trial.
-
Pulmonary rehabilitation in emphysema.Proc Am Thorac Soc. 2008 May 1;5(4):524-9. doi: 10.1513/pats.200707-093ET. Proc Am Thorac Soc. 2008. PMID: 18453366 Free PMC article. Review.
-
Quality of life after lung volume reduction surgery.Thorac Surg Clin. 2004 Aug;14(3):375-83. doi: 10.1016/S1547-4127(04)00029-5. Thorac Surg Clin. 2004. PMID: 15382769 Review.
Cited by
-
An Internet-Mediated Pedometer-Based Program Improves Health-Related Quality-of-Life Domains and Daily Step Counts in COPD: A Randomized Controlled Trial.Chest. 2015 Jul;148(1):128-137. doi: 10.1378/chest.14-1466. Chest. 2015. PMID: 25811395 Free PMC article. Clinical Trial.
-
Correlation of severity of chronic obstructive pulmonary disease with health-related quality of life and six-minute walk test in a rural hospital of central India.Lung India. 2015 May-Jun;32(3):233-40. doi: 10.4103/0970-2113.156231. Lung India. 2015. PMID: 25983408 Free PMC article.
-
The SAFE (SGRQ score, air-flow limitation and exercise tolerance) Index: a new composite score for the stratification of severity in chronic obstructive pulmonary disease.Postgrad Med J. 2007 Jul;83(981):492-7. doi: 10.1136/pgmj.2006.052399. Postgrad Med J. 2007. PMID: 17621621 Free PMC article.
-
Dyspnea and quality of life in patients referred for lung transplantation.Eur J Med Res. 2010 Nov 4;15 Suppl 2(Suppl 2):76-8. doi: 10.1186/2047-783x-15-s2-76. Eur J Med Res. 2010. PMID: 21147626 Free PMC article.
-
Depression is a major determinant of both disease-specific and generic health-related quality of life in people with severe COPD.Chron Respir Dis. 2019 Jan-Dec;16:1479972318775422. doi: 10.1177/1479972318775422. Epub 2018 May 9. Chron Respir Dis. 2019. PMID: 29742914 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- N01HR76101/HR/NHLBI NIH HHS/United States
- N01HR761010/HR/NHLBI NIH HHS/United States
- N01HR761011/HR/NHLBI NIH HHS/United States
- N01HR761012/HR/NHLBI NIH HHS/United States
- N01HR761013/HR/NHLBI NIH HHS/United States
- N01HR761014/HR/NHLBI NIH HHS/United States
- N01HR761015/HR/NHLBI NIH HHS/United States
- N01HR761016/HR/NHLBI NIH HHS/United States
- N01HR761019/HR/NHLBI NIH HHS/United States
- N01HR76102/HR/NHLBI NIH HHS/United States
- N01HR76103/HR/NHLBI NIH HHS/United States
- N01HR76104/HR/NHLBI NIH HHS/United States
- N01HR76105/HR/NHLBI NIH HHS/United States
- N01HR76106/HR/NHLBI NIH HHS/United States
- N01HR76107/HR/NHLBI NIH HHS/United States
- N01HR76108/HR/NHLBI NIH HHS/United States
- N01HR76109/HR/NHLBI NIH HHS/United States
- N01HR76118/HR/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical